Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study.

Ye S, Dunleavey L, Bannister W, Day LB, Tapper W, Collins AR, Day IN, Simpson I; Southampton Atherosclerosis Study.

Eur J Hum Genet. 2003 Jun;11(6):437-43.

2.

Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.

Wang C, Zhou X, Ye S, Han D, Tan X, Zheng F, Shi Q.

Int J Hyg Environ Health. 2006 May;209(3):265-73. Epub 2006 Feb 3.

PMID:
16459141
3.

Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.

Yang JD, Feng GY, Zhang J, Cheung J, St Clair D, He L, Ichimura K.

Neurosci Lett. 2003 Oct 16;350(1):25-8. Erratum in: Neurosci Lett. 2003 May;30(2):215.

PMID:
12962909
4.

Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.

Halimi G, Duplan L, Bideau C, Iniesta D, Berthézène P, Oddoze C, Verdier JM, Michel B, Bergé-Lefranc JL.

Neuroreport. 2000 Nov 9;11(16):3599-601.

PMID:
11095526
5.

Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.

Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Zimmer EL, McNamara DM, Pauly DF, Sharaf B, Holubkov R, Bairey Merz CN, Sopko G, Bontempo F, Kamboh MI.

Circulation. 2003 Jul 1;107(25):3146-51. Epub 2003 Jun 16.

6.

Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.

Wang JC, Kwon JM, Shah P, Morris JC, Goate A.

Neurology. 2000 Dec 12;55(11):1644-9.

PMID:
11113217
7.

[The apolipoprotein E-CI-CII gene cluster polymorphisms and coronary artery disease].

Wang C, Zhou X, Zheng F, Han D, Shi Q, Liu F.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Apr;22(2):164-8. Chinese.

PMID:
15793777
8.

Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.

Parra-Bonilla G, Arboleda G, Yunis J, Solano E, Pardo R, Arango G, Hedmont D, Arboleda H.

Neurosci Lett. 2003 Oct 9;349(3):159-62.

PMID:
12951193
9.

Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients.

Zill P, Engel R, Hampel H, Behrens S, Bürger K, Padberg F, Stübner S, Möller HJ, Ackenheil M, Bondy B.

Eur Arch Psychiatry Clin Neurosci. 2001;251(1):24-8.

PMID:
11315514
10.

Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease.

Viitanen L, Pihlajamäki J, Miettinen R, Kärkkäinen P, Vauhkonen I, Halonen P, Kareinen A, Lehto S, Laakso M.

J Mol Med (Berl). 2001 Dec;79(12):732-7. Epub 2001 Jul 25.

PMID:
11862316
11.

Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.

Bahia VS, Kok F, Marie SN, Shinjo SO, Caramelli P, Nitrini R.

Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):61-5. doi: 10.1097/WAD.0b013e31815a9da7.

PMID:
18317248
12.

Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.

Lambert JC, Araria-Goumidi L, Myllykangas L, Ellis C, Wang JC, Bullido MJ, Harris JM, Artiga MJ, Hernandez D, Kwon JM, Frigard B, Petersen RC, Cumming AM, Pasquier F, Sastre I, Tienari PJ, Frank A, Sulkava R, Morris JC, St Clair D, Mann DM, Wavrant-DeVrièze F, Ezquerra-Trabalon M, Amouyel P, Hardy J, Haltia M, Valdivieso F, Goate AM, Pérez-Tur J, Lendon CL, Chartier-Harlin MC.

Neurology. 2002 Jul 9;59(1):59-66.

PMID:
12105308
13.

[Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].

Wang CH, Zhou X, Zhou GD, Han DF, Zheng F.

Zhonghua Yi Xue Za Zhi. 2004 Apr 2;84(7):554-8. Chinese.

PMID:
15144588
14.

The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.

Town T, Paris D, Fallin D, Duara R, Barker W, Gold M, Crawford F, Mullan M.

Neurosci Lett. 1998 Aug 14;252(2):95-8.

PMID:
9756330
15.

Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults.

Viiri LE, Raitakari OT, Huhtala H, Kähönen M, Rontu R, Juonala M, Hutri-Kähönen N, Marniemi J, Viikari JS, Karhunen PJ, Lehtimäki T.

J Lipid Res. 2006 Jun;47(6):1298-306. Epub 2006 Mar 9.

16.

APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.

Zurutuza L, Verpillat P, Raux G, Hannequin D, Puel M, Belliard S, Michon A, Pothin Y, Camuzat A, Penet C, Martin C, Brice A, Campion D, Clerget-Darpoux F, Frebourg T.

Eur J Hum Genet. 2000 Sep;8(9):713-6.

17.

Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.

Viiri LE, Viiri KM, Ilveskoski E, Huhtala H, Mäki M, Tienari PJ, Perola M, Lehtimäki T, Karhunen PJ.

Circ Cardiovasc Genet. 2008 Dec;1(2):107-16. doi: 10.1161/CIRCGENETICS.108.791764. Epub 2008 Oct 15.

18.

APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.

Tycko B, Lee JH, Ciappa A, Saxena A, Li CM, Feng L, Arriaga A, Stern Y, Lantigua R, Shachter N, Mayeux R.

Arch Neurol. 2004 Sep;61(9):1434-9. Erratum in: Arch Neurol. 2005 Feb;62(2):332.

PMID:
15364690
19.

APOE promoter polymorphisms and dementia in the elderly.

Lambert JC, Berr C, Cottel D, Amouyel P, Helbecque N.

Neurosci Lett. 2004 Jul 22;365(2):116-9.

PMID:
15245790
20.

Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction.

Um JY, Moon KS, Lee KM, Cho KH, Heo Y, Moon BS, Kim HM.

J Mol Neurosci. 2003;21(1):23-8.

PMID:
14500990
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk